Ping Cheung Lam
Président chez MINGYUAN MEDICARE DEVELOPMENT CO., LTD.
Postes actifs de Ping Cheung Lam
Sociétés | Poste | Début | Fin |
---|---|---|---|
MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Président | 20/05/2016 | - |
Historique de carrière de Ping Cheung Lam
Anciens postes connus de Ping Cheung Lam
Sociétés | Poste | Début | Fin |
---|---|---|---|
OSHIDORI INTERNATIONAL HOLDINGS LIMITED | Directeur/Membre du Conseil | 27/03/2012 | 21/05/2015 |
Independent Dir/Board Member | 27/03/2012 | 21/05/2015 | |
GOLDEN RESOURCES DEVELOPMENT INTERNATIONAL LIMITED | Directeur/Membre du Conseil | 13/10/2011 | 30/08/2012 |
Independent Dir/Board Member | 13/10/2011 | 30/08/2012 | |
SEAMLESS GREEN CHINA (HOLDINGS) LIMITED | Directeur/Membre du Conseil | 01/01/2010 | 04/08/2011 |
C C LAND HOLDINGS LIMITED | Directeur/Membre du Conseil | - | 22/06/2006 |
Lam & Co. (Hong Kong) | Fondateur | - | - |
Corporate Officer/Principal | - | - |
Formation de Ping Cheung Lam
The Chinese University of Hong Kong | Undergraduate Degree |
Statistiques
Internationale
Hong Kong | 8 |
Opérationnelle
Director/Board Member | 4 |
Independent Dir/Board Member | 2 |
Undergraduate Degree | 1 |
Sectorielle
Finance | 3 |
Retail Trade | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
C C LAND HOLDINGS LIMITED | Finance |
GOLDEN RESOURCES DEVELOPMENT INTERNATIONAL LIMITED | Retail Trade |
SEAMLESS GREEN CHINA (HOLDINGS) LIMITED | Electronic Technology |
OSHIDORI INTERNATIONAL HOLDINGS LIMITED | Finance |
Entreprise privées | 2 |
---|---|
Lam & Co. (Hong Kong) | |
Mingyuan Medicare Development Co. Ltd.
Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
- Bourse
- Insiders
- Ping Cheung Lam
- Expérience